“And I expect that to continue just because of these deep investments and still considering this very early innings, third inning in terms of the build that we'd like to see looking ahead for care delivery.”

In context

“out it now with you here, I'm talking about even our existing base of clinical care delivery capabilities and where we have to build out that capability in terms of future value-based expansion. We're still quite early stage in that, which is why we hang in this 8% to 10% margin range for Optum Health, view being here that there is a decade ahead of build for us, so. And just when you look at our existing pipeline and what that can drive in terms of strong double-digit top line growth for many years as we bring this on. And the importance, in particular because of the value it brings to the patients we serve, of continuing to invest in these value-based capabilities. So as we build along this, you'll see as we try to do this, we try to -- we look to deliver in this 8% to 10% margin range. And I expect that to continue just because of these deep investments and still considering this very early innings, third inning in terms of the build that we'd like to see looking ahead for care delivery. Andrew Witty : John, thank you very much. Kevin, I appreciate the question. Next question, please. Operator: We'll go next to Whit Mayo with SVB Securities. Whit Mayo: I would have thought that investment income would have been a little higher this quarter. Were there any write-downs on Optum Ventures, anything that would negatively impact that? Just wondering how you're marking some of those investments that you've made in recent years. Andrew Witty : Yes. Well, thanks so much. Let me hand it straight to John. John Rex: Good morning, Whit. Yes, within the quarter, we actually took -- we realized some losses as we reposition the portfolio a bit here, looking out to the future, try to get that all teed up for the environment we're in right now. And so when you look at that, the quarterly p”